Eli Lilly

Company · 2 documents

Key number

US$191 billion US$ billion

Total Life Sciences M&A Value. EY p.3

Key number

US$1.3t USD

M&A Firepower in 2025. EY p.5

ReportEYJanuary 202520 pages

Life sciences M&A deal value fell 41% in 2024 to US$130b as biopharma integrated prior large acquisitions.

ReportEYJanuary 202432 pages

Total life sciences M&A deal value reached US$191 billion by mid-December 2023, representing a 34% increase compared to 2022.